Assessing intermediate clinical endpoints (ICE) as potential surrogates for overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC) Meeting Abstract
| Authors: | Halabi, S.; Roy, A.; Rydzewska, L.; Godolphin, P.; Parmar, M. K. B.; Hussain, M. H. A.; Tangen, C.; Thompson, I.; Xie, W.; Carducci, M. A.; Smith, M. R.; Morris, M. J.; Gravis, G.; Dearnaley, D. P.; Verhagen, P.; Goto, T.; James, N. D.; Buyse, M. E.; Tierney, J. F.; Sweeney, C. |
| Abstract Title: | Assessing intermediate clinical endpoints (ICE) as potential surrogates for overall survival (OS) in men with metastatic hormone-sensitive prostate cancer (mHSPC) |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680301423 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.5006 |
| Notes: | Meeting Abstract: 5006 -- This meeting was also held virtually -- Source: Wos |
